Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CASP3 | P42574 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.34 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.34 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL814840 | 0.83 | — | — | |
| SCHEMBL6891127 | 0.83 | CYP2C19 (0.32) | — | |
| SCHEMBL1305186 | 0.81 | SHBG (0.36) | SMN1; SMN2TAAR1 | |
| SCHEMBL7726075 | 0.81 | TSHR (0.33) | TAAR1 | |
| SCHEMBL19405395 | 0.81 | TAAR1 (0.30) | TAAR1 | |
| SCHEMBL3596575 | 0.81 | TAAR1 (0.48) | TAAR1 | |
| SCHEMBL19405434 | 0.81 | — | — | |
| SCHEMBL19405565 | 0.81 | TAAR1 (0.30) | TAAR1 | |
| SCHEMBL2696388 | 0.81 | TAAR1 (0.30) | TAAR1 | |
| SCHEMBL814780 | 0.80 | CNR2 (0.33) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 477 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3726636-B1 | ELECTROLYTE SOLUTION FOR NONAQUEOUS ELECTROLYTE BATTERIES AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | CENTRAL GLASS CO LTD (JP) | 2024-06-26 | — | — | EP | claimed |
| CN-116332978-B | Organic compound, preparation method thereof and organic electroluminescent device comprising organic compound | 吉林奥来德光电材料股份有限公司 | 2023-08-29 | — | — | CN | claimed |
| CN-111527636-B | Electrolyte for nonaqueous electrolyte battery and nonaqueous electrolyte battery using same | 中央硝子株式会社 | 2023-08-15 | — | — | CN | claimed |
| US-20230250200-A1 | IMPROVED CATALYSTS FOR INTERMOLECULAR CYCLOADDITION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-08-10 | — | — | US | claimed |
| CN-116332978-A | Organic compound, preparation method thereof and organic electroluminescent device comprising organic compound | 吉林奥来德光电材料股份有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-113493870-B | Composite flocculant for ion type rare earth enrichment and enrichment method | 福建省长汀金龙稀土有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-115304601-A | Acridine-containing fused ring derivative and application thereof | 北京鼎材科技有限公司 | 2022-11-08 | — | — | CN | claimed |
| CN-114502543-A | Targeted protein compounds, pharmaceutical compositions and therapeutic applications thereof | 拜欧斯瑞克斯公司 | 2022-05-13 | — | — | CN | claimed |
| CN-113493870-A | Composite flocculant for ion type rare earth enrichment and enrichment method | 厦门钨业股份有限公司 | 2021-10-12 | — | — | CN | claimed |
| WO-2021126692-A1 | IRON BIS(IMINO) ARYL CATALYSTS AND METHODS THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-06-24 | — | — | WO | claimed |
| EP-1648886-B1 | BENZOXAZINONE-DERIVED SULFONAMIDE COMPOUNDS, THEIR PREPARATION AND USE AS MEDICAMENTS | ESTEVE LABOR DR (ES) | 2009-12-09 | — | — | EP | claimed |
| US-7247687-B2 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-07-24 | — | — | US | claimed |
| US-20070032482-A1 | Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments | LABORATORIOS DEL DR. ESTEVE S.A. (ES) | 2007-02-08 | — | — | US | claimed |
| EP-1735293-A2 | SUBSTITUTED HYDROXYETHYLAMINE ASPARTYL PROTEASE INHIBITORS | ELAN PHARMACEUTICALS, INC. (US) | 2006-12-27 | — | — | EP | claimed |
| EP-1521758-B1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2006-05-24 | — | — | EP | claimed |
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-03-02 | — | — | US | claimed |
| WO-2005087752-A2 | SUBSTITUTED HYDROXYETHYLAMINE ASPARTYL PROTEASE INHIBITORS | ELAN PHARMACEUTICALS, INC. (US) | 2005-09-22 | — | — | WO | claimed |
| EP-1521758-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2005-04-13 | — | — | EP | claimed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | claimed |
| US-4134877-A | Flame retardant phosphoramidate compositions | MONSANTO COMPANY (US) | 1979-01-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070032482-A1 | Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments | HTR6, HTR5A, P2RX6 | NPC1 3828/4885LMNA 3123/4885MAPK1 3300/4885 |
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | MLX, LOX, LMTK3 | NPC1 3851/4885LMNA 178/4885MAPK1 2374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.